ArticleACS medicinal chemistry letters2016

Novel Oxindole Sulfonamides and Sulfamides: EPZ031686, the First Orally Bioavailable Small Molecule SMYD3 Inhibitor.

Lorna H Mitchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.